← Open Payments lookup

PRITESH SHAH: Open Payments

NPI 1114121175 · WESTWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,269 in 71 payments from 13 companies in 2025. Trend: 2023 $801 · 2024 $719 · 2025 $1,269

Food & beverage: $1,269
CompanyPaymentsAmount
ABBVIE INC.22$255
Neurocrine BioSciences, Inc.6$191
Otsuka America Pharmaceutical, Inc.10$167
AstraZeneca Pharmaceuticals LP1$125
Teva Pharmaceuticals USA, Inc.6$98
E.R. Squibb & Sons, L.L.C.6$93
Takeda Pharmaceuticals U.S.A., Inc.5$76
Alkermes, Inc.4$61
Neos Therapeutics, LP3$58
Vanda Pharmaceuticals Inc.3$51

Products named: VRAYLAR, INGREZZA, REXULTI, TEZSPIRE, COBENFY, AUSTEDO XR, TRINTELLIX, HETLIOZ.

Industry payments across NJ — which companies pay providers there.